Etablierung, Optimierung und Anwendung verschiedener Modelle zur Charakterisierung von p38 MAPK Inhibitoren

to related objects

Alternative title: Development, Optimization and Application of test systems for the characterization of p38 MAPK inhibitors

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Deutsch

Notes: Tübingen, Universität Tübingen, Dissertation, 2011

Keyword: Crohn-Krankheit
Inhibitor
Arzneimittelentwicklung
MAP-Kinase
Crohn-Krankheit ; Arzneimittelentwicklung

Event: Veröffentlichung

(where): Tübingen

(who): Universitätsbibliothek Tübingen

(when): 2011

Creator: Fehr, Sarah Nicole

Contributor: Laufer, Stefan

URN: urn:nbn:de:bsz:21-opus-58595

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Fehr, Sarah Nicole
Laufer, Stefan
Universitätsbibliothek Tübingen

Time of origin

2011

Other Objects (12)

Synthesis and investigation of novel p38 MAPK and DDR kinase inhibitors

Wirkung unterschiedlicher p38 MAPK-Inhibitoren auf das funktionelle Verhalten von Mammakarzinomzellen Inauguraldissertation

p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics

Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects

Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer

P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells

Serum amyloid A inhibits astrocyte migration via activating p38 MAPK

Bedeutung der Mitogen Aktivierten Proteinkinase (MAPK) P38 bei der Hypertonieentstehung

Synthesis of a p38 Kinase Inhibitor

Specific inhibitor of MEK-mediated cross-talk between ERK and p38 MAPK during differentiation of human osteosarcoma cells

Nr4a1 promotes renal interstitial fibrosis by regulating the p38 MAPK phosphorylation

p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance

Synthesis and investigation of novel p38 MAPK and DDR kinase inhibitors

Wirkung unterschiedlicher p38 MAPK-Inhibitoren auf das funktionelle Verhalten von Mammakarzinomzellen Inauguraldissertation

p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics

Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects

Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer

P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells

Serum amyloid A inhibits astrocyte migration via activating p38 MAPK

Bedeutung der Mitogen Aktivierten Proteinkinase (MAPK) P38 bei der Hypertonieentstehung

Synthesis of a p38 Kinase Inhibitor

Specific inhibitor of MEK-mediated cross-talk between ERK and p38 MAPK during differentiation of human osteosarcoma cells

Nr4a1 promotes renal interstitial fibrosis by regulating the p38 MAPK phosphorylation

p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance

Synthesis and investigation of novel p38 MAPK and DDR kinase inhibitors

Wirkung unterschiedlicher p38 MAPK-Inhibitoren auf das funktionelle Verhalten von Mammakarzinomzellen Inauguraldissertation

p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics

Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects

Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer

P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells

Serum amyloid A inhibits astrocyte migration via activating p38 MAPK

Bedeutung der Mitogen Aktivierten Proteinkinase (MAPK) P38 bei der Hypertonieentstehung

Synthesis of a p38 Kinase Inhibitor

Specific inhibitor of MEK-mediated cross-talk between ERK and p38 MAPK during differentiation of human osteosarcoma cells

Nr4a1 promotes renal interstitial fibrosis by regulating the p38 MAPK phosphorylation

p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Etablierung, Optimierung und Anwendung verschiedener Modelle zur Charakterisierung von p38 MAPK Inhibitoren

Object Details

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Synthesis and investigation of novel p38 MAPK and DDR kinase inhibitors

Wirkung unterschiedlicher p38 MAPK-Inhibitoren auf das funktionelle Verhalten von Mammakarzinomzellen Inauguraldissertation

p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics

Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects

Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer

P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells

Serum amyloid A inhibits astrocyte migration via activating p38 MAPK

Bedeutung der Mitogen Aktivierten Proteinkinase (MAPK) P38 bei der Hypertonieentstehung

Synthesis of a p38 Kinase Inhibitor

Specific inhibitor of MEK-mediated cross-talk between ERK and p38 MAPK during differentiation of human osteosarcoma cells

Nr4a1 promotes renal interstitial fibrosis by regulating the p38 MAPK phosphorylation

p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance

Synthesis and investigation of novel p38 MAPK and DDR kinase inhibitors

Wirkung unterschiedlicher p38 MAPK-Inhibitoren auf das funktionelle Verhalten von Mammakarzinomzellen Inauguraldissertation

p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics

Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects

Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer

P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells

Serum amyloid A inhibits astrocyte migration via activating p38 MAPK

Bedeutung der Mitogen Aktivierten Proteinkinase (MAPK) P38 bei der Hypertonieentstehung

Synthesis of a p38 Kinase Inhibitor

Specific inhibitor of MEK-mediated cross-talk between ERK and p38 MAPK during differentiation of human osteosarcoma cells

Nr4a1 promotes renal interstitial fibrosis by regulating the p38 MAPK phosphorylation

p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance

Synthesis and investigation of novel p38 MAPK and DDR kinase inhibitors

Wirkung unterschiedlicher p38 MAPK-Inhibitoren auf das funktionelle Verhalten von Mammakarzinomzellen Inauguraldissertation

p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics

Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects

Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer

P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells

Serum amyloid A inhibits astrocyte migration via activating p38 MAPK

Bedeutung der Mitogen Aktivierten Proteinkinase (MAPK) P38 bei der Hypertonieentstehung

Synthesis of a p38 Kinase Inhibitor

Specific inhibitor of MEK-mediated cross-talk between ERK and p38 MAPK during differentiation of human osteosarcoma cells

Nr4a1 promotes renal interstitial fibrosis by regulating the p38 MAPK phosphorylation

p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance

Related objects

Reset password